Publisher
Springer Science and Business Media LLC
Subject
Physical and Theoretical Chemistry,Computer Science Applications,Drug Discovery
Reference17 articles.
1. Werth B (1995) The billion dollar molecule: one company’s quest for the perfect drug, revised edn. Simon & Schuster, New York
2. Werth B (2014) The antidote: inside the world of new pharma, reprint edn. Simon & Schuster, New York
3. Clark M, Ledeboer M, Davies I, Byrn R, Jones S, Perola E, Tsai A, Jacobs M, Nti-Addae K, Bandarage U, Boyd M, Bethiel R, Court J, Deng H, Duffy J, Dorsch W, Farmer L, Gao H, Gu W, Jackson K, Jacobs D, Kennedy J, Ledford B, Liang J, Maltais F, Murcko M, Wang T, Wannamaker M, Bennett H, Leeman J, McNeil C, Taylor W, Memmott C, Jiang M, Rijnbrand R, Bral C, Germann U, Nezami A, Zhang Y, Salituro FG, Bennani YL, Charifson P (2014) Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2”. J Med Chem 57(2014):6668–6678
4. Charifson PS, Grillot A-L, Grossman TH, Parsons JD, Badia M, Bellon S, Deininger DD, Drumm JE, Gross CH, LeTiran A, Liao Y, Mani N, Nicolau DP, Perola E, Ronkin S, Shannon D, Swenson LL, Tang Q, Tessier PR, Tian SK, Trudeau M, Wang T, Wei Y, Zhang H, Stamos D (2008) Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships. J Med Chem 51:5243–5263
5. Perola E, Stamos D, Grillot AL, Ronkin S, Wang T, LeTiran A, Tang Q, Deininger DD, Liao Y, Tian SK, Drumm JE, Nicolau DP, Tessier PR, Mani N, Grossman TH, Charifson PS (2014) Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacy Bioorg. Med Chem Lett 24:2177–2181
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献